In experimental studies, oral supplementation with sodium butyrate was found to inhibit the NF-κB inflammatory signaling pathway, function as an HDAC inhibitor and modulate gene expression, and most importantly, protect intestinal health in animal models, alleviating chronic colitis and acute DSS-induced colitis [24]. The gene discussed is NFKB1; the disease is colitis.